Cold Plasma Synthesis of Silver Nanoparticles in Tissue

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for synthesizing nanoparticles for medical treatments, such as silver nanoparticles, are costly, involve safety concerns, and face challenges in maintaining dispersion and preventing aggregation, which can affect their efficacy in treating wounds and infections.

Innovation Solution

The use of cold plasma technology to synthesize silver nanoparticles or other metal nanoparticles within cells, tissues, or liquid media, allowing for in-situ generation and dispersion to prevent aggregation, with a hand-held device generating multiple-frequency cold plasma that facilitates nanoparticle formation and bactericidal effects.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If conventional methods are used to synthesize nanoparticles, then nanoparticle production is achieved, but the process is costly and involves safety concerns

Engineering Contradiction:
Improvenanoparticle synthesis processVSAvoidsafety and cost effectiveness
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent replaces conventional chemical synthesis methods with cold plasma technology. The cold plasma device generates reactive species and energy that directly reduce metal ions to nanoparticles without requiring costly chemical reagents or complex purification systems, thereby reducing costs and improving safety

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The cold plasma synthesis process is self-regulating through the natural behavior of plasma. The plasma automatically controls nanoparticle formation, size distribution, and prevents aggregation through its reactive environment, eliminating the need for additional stabilizing agents or complex process control mechanisms

Inventive Principle:
Principle #25Self-service

2Reliability

If high concentrations of nanoparticles are used to ensure efficacy, then treatment effectiveness improves, but cytotoxicity and biofilm formation increase

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidcytotoxicity and biofilm formation
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The cold plasma process fundamentally changes the parameters of nanoparticle synthesis by producing particles with specific surface properties and size distributions directly during synthesis. The plasma environment creates nanoparticles with inherent stability and controlled morphology that achieve therapeutic effects at lower concentrations, reducing cytotoxicity and biofilm formation risks

Inventive Principle:
Principle #35Parameter changes

3Device complexity

If nanoparticles are synthesized without in-situ generation, then synthesis process is simpler, but aggregation occurs and dispersion is difficult to maintain

Engineering Contradiction:
Improvesynthesis processVSAvoidnanoparticle dispersion
Core Design Contradiction:
Device complexityVSStability of the object's composition

Solution Approach 1:

The cold plasma process performs preliminary stabilization actions during the nanoparticle synthesis itself. The plasma environment provides continuous stabilization that prevents aggregation as particles form and mature, ensuring long-term dispersion stability without requiring additional stabilization steps or complex device configurations

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables effective bactericidal action, accelerates tissue healing, and reduces infection levels by ensuring uniform nanoparticle distribution and reducing the need for high concentrations, while minimizing cytotoxicity and biofilm formation.

Implementation Method 1

synthesis of nanoparticles in liquid, semi-solid media and in cells using cold plasma technology

Methodology Applied
Scientific EffectCold plasma: Plasma

Implementation Method 2

The energy source may include, but is not limited to, a dielectric barrier discharge energy system

Methodology Applied
Scientific EffectDielectric barrier discharge:

Implementation Method 3

the metal ions may be reduced to the metal atoms by the cold plasma

Methodology Applied
Scientific EffectReduction: Reduction

Implementation Method 4

The cold plasma may also introduce reactive oxygen and nitrogen species that are bactericidal to the bacteria

Methodology Applied
Scientific EffectReactive oxygen and nitrogen species: Oxidation

Data Source

PatentUS20230293739A1Synthesis Of Nanoparticle In Liquid, Semi-Solid Media And In Cells And Tissues Using Cold Plasma Technology
Publication Date: 2023.09.21 PLASMOLOGY4 INC
  • US20230293739A1 patent drawing
  • US20230293739A1 patent drawing
  • US20230293739A1 patent drawing

AI summary

A method of forming metal nanoparticles includes applying a substance to an area of interest, applying cold plasma to the area of interest, and synthesizing nanoparticles from the substance using the cold plasma in the area of interest, wherein the substance is a solution that contains metal ions, and the nanoparticles synthesized are metallic in nature.